NCT06215950View on ClinicalTrials.gov

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Ovarian CancerCervix CancerMetastatic CancerAdvanced CancerGynecologic Cancer
Interventions
BIOLOGICAL

CD70 CAR-T cells

After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were transfused intravenically

BIOLOGICAL

CD70 CAR-T cells

After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were injected intraperitoneally

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Wannan Medical College, Wuhu

All Listed Sponsors
lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY